Spectranetics to Hold 2014 Fourth Quarter Financial Results Conference Call on February 19
06 February 2015 - 8:01AM
The Spectranetics Corporation (Nasdaq:SPNC) today announced that
the Company will release 2014 fourth quarter financial results
after market close on Thursday, February 19, 2015. Company
management will host an investment-community conference call
beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on
Thursday, February 19 to discuss those results and to answer
questions.
Individuals interested in listening to the conference call may
do so by dialing (877) 561-2747 for domestic callers, or (973)
409-9689 for international callers, or from the webcast on the
investor relations section of the Company's website at:
www.spectranetics.com. The webcast will be available on the
Company's website for 14 days following the completion of the
call.
About Spectranetics
Spectranetics develops, manufactures, markets and distributes
single-use medical devices used in minimally invasive procedures
within the cardiovascular system. The company's products are sold
in over 65 countries and are used to treat arterial blockages in
the heart and legs and in the removal of pacemaker and
defibrillator leads.
In June 2014, Spectranetics acquired AngioScore Inc., a leading
developer, manufacturer and marketer of cardiovascular, specialty
balloons.
The Company's Vascular Intervention (VI) products include a
range of laser catheters for ablation of blockages in arteries
above and below the knee as well as the AngioSculptĀ® scoring
balloon used in both peripheral and coronary procedures. The
Company also markets support catheters to facilitate crossing of
peripheral and coronary arterial blockages, and retrograde access
and guidewire retrieval devices used in the treatment of peripheral
arterial blockages, including chronic total occlusions. The company
markets aspiration and cardiac laser catheters to treat blockages
in the heart.
The Lead Management (LM) product line includes excimer laser
sheaths, mechanical sheaths and accessories for the removal of
pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
CONTACT: COMPANY CONTACTS:
Spectranetics Corporation
Guy Childs, Chief Financial Officer
(719) 633-8333
INVESTOR CONTACTS:
Westwicke Partners, LLC
Lynn Pieper
(415) 202-5678
lynn.pieper@westwicke.com
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Apr 2024 to May 2024
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about The Spectranetics Corp. (MM) (NASDAQ): 0 recent articles
More News Articles